Why Biotechnology Company Carmell Shares Are Seeing Blue Skies Tuesday?
Why Biotechnology Company Carmell Shares Are Seeing Blue Skies Tuesday?
Carmell Corporation (NASDAQ:CTCX) shares are trading higher after it entered into a securities purchase agreement with new and existing investors.
Carmell Corporation (納斯達克:CTCX) 股票在與新老投資者簽署證券購買協議後交易上漲。
The agreement involves the issuance and sale of 8,065,210 shares of common stock and an equal number of five-year warrants, both priced at $0.23 per share, in a private placement.
該協議涉及發行和出售8,065,210股普通股,以及數量相同的五年期Warrants,二者的售價均爲每股$0.23,屬於定向增發。
The transaction is expected to generate gross proceeds of $1.85 million before offering expenses and fees.
該交易預計在扣除發行費用和費用之前將產生185萬的總收入。
If the warrants are exercised, Carmell could receive an additional $1.85 million.
如果Warrants被行使,Carmell可能會獲得額外的185萬。
The Private Placement was priced slightly above CTCX's closing price on Dec. 23, 2024.
定向增發的定價略高於2024年12月23日CTCX的收盤價。
Following the closing of the Private Placement, Carmell Corporation will have approximately 29 million shares of common stock outstanding.
在定向增發結束後,Carmell Corporation將擁有約2900萬股普通股。
The warrants can be exercised starting the trading day after the Stockholder Approval Date and continue until the fifth anniversary of the warrant issue date.
Warrants可以在股東批准日期後的第一個交易日開始行使,並持續到Warrant發行日期的五週年。
The warrants allow for the purchase of up to 8.1 million shares of Carmell's common stock at an exercise price of $0.23 per share.
這些Warrants允許以每股$0.23的行使價格購買高達810萬股Carmell的普通股。
The closing of the Private Placement is subject to customary conditions.
定向增發的完成需滿足慣例條件。
Price Action: CTCX shares are up 20% at $0.27 at last check Tuesday.
價格走勢:CTCX 股票在週二最後檢查時上漲 20%,報 $0.27。
Read Next:
下一步閱讀:
- Warren Buffett Heads Into 2025 With $325 Billion Cash Pile, His Largest in Over Three Decades: Expert Says It 'Will Provide An Opportunity For The Successors To Make Their Own Mark'
- 禾倫·巴菲特以3250億美元的現金儲備邁入2025年,這是他三十多年以來的最大現金儲備:專家表示,這"將爲接班人提供展示自己的機會"
Photo: Shutterstock
Photo: Shutterstock